Tezepelumab treatment in severe asthma with recurrent chronic rhinosinusitis with nasal polyps: Case series
Background: Tezepelumab is a human IgG2 mAb that inhibits thymic stromal lymphopoietin (TSLP) and is approved for treatment of severe asthma. Bronchial asthma, usually a type 2 inflammatory disease, often co-occurs with chronic rhinosinusitis with nasal polyps (CRSwNP). However, tezepelumab has unkn...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2025-05-01
|
| Sarja: | Journal of Allergy and Clinical Immunology: Global |
| Aiheet: | |
| Linkit: | http://www.sciencedirect.com/science/article/pii/S2772829324001929 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|